Tag: HRR mutations

Radiation plus hormone therapy may improve prostate cancer survival

Pfizer’s Talzenna combo significantly delays prostate cancer progression

byDeepti Shroff

April 9, 2026

1. The combination of talazoparib and enzalutamide demonstrated a statistically significant improvement in radiographic progression-free survival for metastatic hormone-sensitive prostate ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

High-flow nasal oxygen therapy may not be superior to standard oxygen therapy after cardiac surgery
Segment 4b/5 resection offers no survival advantage over wedge resection in gallbladder cancer
Simvastatin (Zocor) in combination with paclitaxel (Taxol) may provide treatment benefit compared to paclitaxel alone for small cell lung cancer

No Result

View All Result